Mechanistic Target of Rapamycin Inhibitors: Successes and Challenges as Cancer Therapeutics

doi 10.20517/cdr.2019.87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy